Key points from the Review Article "GLP-1 Receptor Agonists"
A new review by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, describes a new generation of treatment with GLP-1 receptor agonists for persons with obesity with or without diabetes or prediabetes. Learn more: nej.md/4sUFlys
@tuftsmedschool.bsky.social @cjrosenlab.bsky.social